JPRN-UMIN000018626
Completed
Phase 2
Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty using Titanium Bridges - Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty using Titanium Bridges
ConditionsAdductor Spasmodic Dysphonia
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Adductor Spasmodic Dysphonia
- Sponsor
- Kumamoto University
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Dysphagia, laryngeal paralysis, or any structural disorder in the vocal cord 2\. Previous surgery for adductor spasmodic dysphonia 3\. Local injection of botulinum toxin type A into the intralaryngeal muscles within 6 months before informed consent 4\. Serious concomitant diseases 5\. Surgery with general anesthesia scheduled during the study period or surgery performed within the past 4 weeks 6\. Participation in any other study using any other intervention within 12 weeks before informed consent, or planned participation in such a study during the study period after enrollment in this study 7\. Psychiatric disorder requiring treatment, or mental or intellectual disability that may affect the conduct of the study 8\. A history of alcoholism or drug abuse 9\. A history of hypersensitivity to pure titanium 10\. Women who are pregnant or planning to become pregnant during the study period 11\. Patients deemed ineligible for this study by the investigator for any other reason
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium BridgesAdductor Spasmodic DysphoniaNCT02528006Kumamoto University20
Recruiting
Not Applicable
RSSDJPRN-UMIN000039810agoya City University Graduate School of Medical Sciences2,000
Completed
Not Applicable
The Spasmodic Dysphonia (SD): Epidemiology and Patient ManagementG24.8Other dystoniaDRKS00019933MED-EL Elektromedizinische Geräte GmbH56
Completed
Phase 1
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic DysphoniaAdductor Spasmodic DysphoniaVoice DisordersSpasmodic DysphoniaNCT05158166University of California, San Francisco22
Not yet recruiting
Phase 2
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic DysphoniaSpasmodic DysphoniaNCT04938154University of British Columbia16